Forbion co-founder warns European biotech lacks early stage venture capital
Sander Slootweg says European biotech is limited by a shortage of early stage venture capital rather than late stage scale-up funds.
FTMQ Startups, written by our newsroom0 views
Sander Slootweg, co-founder and managing partner of European life sciences venture firm Forbion, stated at the Jefferies Global Healthcare Conference in London that Europe faces a shortage of early stage biotech venture capital. Speaking on the BiotechTV podcast, Slootweg argued that the constraint on European biotechnology has shifted from late stage scale-up capital to early stage funding, as reported by BigGo Finance. [1]
BigGo Finance reported that Slootweg highlighted a lack of early stage venture capital firms and noted that several existing early stage funds are struggling to raise capital. Slootweg stated that the long held view that Europe primarily lacks late stage capital to build commercial drug companies is now out of date. [1]
As FTMQ Startups reported earlier, Forbion closed 2.3 billion euros, equivalent to 2.6 billion dollars, across two venture funds named Forbion Growth Opportunities IV and Forbion Ventures Fund VIII in October 2026. BigGo Finance noted that Forbion was the most active lead investor globally in private biotech financings in 2025. [1][5]
In short
- Sander Slootweg stated that Europe faces a lack of early stage biotech capital and early stage venture firms.
- Forbion was the most active lead investor in private biotech financings globally in 2025.
- Forbion previously raised 2.3 billion euros across two venture funds.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Forbion's Sander Slootweg: Europe's Biotech Problem Isn't Too Little Money — It's Where the Money GoesBigGo Finance, 2d ago (the report this story comes from)
Background
- [2]Sam Altman on Wikipedia
- [3]Invest Europe on Wikipedia
- [4]Money on Wikipedia
- [5]Forbion Raises Record 2.3 Billion Euros Across Two Venture Funds FTMQ Startups, 45d ago
Our newsroom writes these reports with the help of software, from the 5 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Startups
Earlier reports of ours on the same people and subjects.
- Forbion Raises Record 2.3 Billion Euros Across Two Venture FundsVenture Capital, 45d ago
- Box Group David Tisch disputes concentrated seed fund win rate claimsFunding Rounds, 20d ago
- Venture capital funds shorten fundraising cycles to under two yearsVenture Capital, 20d ago
- Disruptive launches $10 billion flagship fund for concentrated tech investmentsVenture Capital, 24d ago
- Dren Bio secures 350 million dollars for lead cancer drug launchFunding Rounds, 21d ago
More in Venture Capital
- Los Angeles Pension Commits Additional 30 Million Dollars to Townsend Real Estate15h ago
- Oberland Capital Healthcare Solutions II reports 796 million dollars raised15h ago
- Foundry Investment Management closes third fund at 120 million dollars1d ago
- Pegasus Tech Ventures and Taisei Corporation Launch 150 Million Dollar CVC Initiative3d ago
- Blue Sea Capital closes fourth fund at 800 million dollars3d ago
- Premier Partners Raises Co-Investment Fund for Korea Fund Partners Acquisition5d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.